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background: Initial management of acute coronary syndrome (ACS) frequently involves percutaneous coronary intervention (PCI). This study 
characterized the real-world experience of US patients before, during, and after hospitalization for ACS-PCI.
Methods: This retrospective cohort study used US administrative claims and hospital billing record data. We included ACS-PCI patients aged ≥18 
with a hospitalization carrying a primary diagnosis of ACS between 1/1/2009-12/31/2011 (index admission). Patients with an ACS admission in 
the prior 12 months, and those not undergoing PCI during the index admission were excluded. Patients were classified into one of two samples: a 
“Claims sample” was drawn from administrative claims; a “Hospital Drug Data (HDD) sample” was drawn from hospital billing records. Statistical 
analyses included univariate, bivariate, and Kaplan-Meier (KM) survival analyses. Patient characteristics, in-hospital mortality, length of stay (LOS), 
inpatient and post-discharge pharmacological treatments, readmissions, mortality, and healthcare costs were reported.
results: There were 39,290 patients in the Claims sample and 106,486 patients in the HDD sample; mean ages 60 to 63 years. The index 
admission’s median LOS was 3-4 days (depending on sample) and median costs were $25,416. Approximately 2% of patients died during the index 
admission. After the PCI was performed, 86% to 89% of patients received aspirin and/or clopidogrel in hospital. The KM-estimated probabilities of 
all-cause readmissions and mortality, respectively, were 16% and 3% by 30 days and 43% and 7% by 2 years after discharge. The median per-patient 
total healthcare costs, excluding the index admission costs, were $1,392 by 30 days and $21,841 by 2 years after discharge.
conclusions: This is one of the first and largest claims database analyses to report on the clinical and economic burden of ACS-PCI patients. ACS-
PCI patients incurred substantial LOS and in-hospital costs. Among those surviving to discharge, 30-day all-cause readmissions were common and 
the 30-day mortality rate was higher than previous reports based on PCI patients with or without ACS.
